131 related articles for article (PubMed ID: 22030099)
1. Association between PON1 activity and coronary heart disease risk: a meta-analysis based on 43 studies.
Zhao Y; Ma Y; Fang Y; Liu L; Wu S; Fu D; Wang X
Mol Genet Metab; 2012 Jan; 105(1):141-8. PubMed ID: 22030099
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of the influence of paraoxonase 1 activity and coronary heart disease risk.
Wang M; Lang X; Cui S; Zou L; Cao J; Wang S; Wu X
DNA Cell Biol; 2012 Jun; 31(6):975-82. PubMed ID: 22320866
[TBL] [Abstract][Full Text] [Related]
3. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O
Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578
[TBL] [Abstract][Full Text] [Related]
4. Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?
Mackness M; Mackness B
Free Radic Biol Med; 2004 Nov; 37(9):1317-23. PubMed ID: 15454272
[TBL] [Abstract][Full Text] [Related]
5. Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women.
van Himbergen TM; van der Schouw YT; Voorbij HA; van Tits LJ; Stalenhoef AF; Peeters PH; Roest M
Atherosclerosis; 2008 Aug; 199(2):408-14. PubMed ID: 18164014
[TBL] [Abstract][Full Text] [Related]
6. High C-reactive protein and low paraoxonase1 in diabetes as risk factors for coronary heart disease.
Mackness B; Hine D; McElduff P; Mackness M
Atherosclerosis; 2006 Jun; 186(2):396-401. PubMed ID: 16140307
[TBL] [Abstract][Full Text] [Related]
7. Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study.
Mackness B; Durrington P; McElduff P; Yarnell J; Azam N; Watt M; Mackness M
Circulation; 2003 Jun; 107(22):2775-9. PubMed ID: 12756158
[TBL] [Abstract][Full Text] [Related]
8. [Low paraoxonase and arylesterase plasma activities in Mexican patients with coronary artery disease].
Gamboa R; Regalado JC; Huesca-Gómez C; Posadas-Romero C; Verdejo Paris J; Vargas-Alarcón G; Pérez-Méndez O
Arch Cardiol Mex; 2008; 78(4):360-8. PubMed ID: 19205543
[TBL] [Abstract][Full Text] [Related]
9. PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients.
Kotur-Stevuljevic J; Spasic S; Jelic-Ivanovic Z; Spasojevic-Kalimanovska V; Stefanovic A; Vujovic A; Memon L; Kalimanovska-Ostric D
Clin Biochem; 2008 Sep; 41(13):1067-73. PubMed ID: 18634772
[TBL] [Abstract][Full Text] [Related]
10. Four genetic polymorphisms of paraoxonase gene and risk of coronary heart disease: a meta-analysis based on 88 case-control studies.
Wang M; Lang X; Zou L; Huang S; Xu Z
Atherosclerosis; 2011 Feb; 214(2):377-85. PubMed ID: 21146823
[TBL] [Abstract][Full Text] [Related]
11. The correlation of homocysteine-thiolactonase activity of the paraoxonase (PON1) protein with coronary heart disease status.
Domagała TB; Łacinski M; Trzeciak WH; Mackness B; Mackness MI; Jakubowski H
Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(5):4-10. PubMed ID: 17543199
[TBL] [Abstract][Full Text] [Related]
12. [Study of the association between paraoxonase1 55 Met/Leu, paraoxonase2 148 Ala/Gly and manganese superoxide dismutase (MnSOD) 9 Ala/Val genetic polymorphisms and coronary heart disease].
Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Sep; 27(9):808-13. PubMed ID: 17299970
[TBL] [Abstract][Full Text] [Related]
13. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
Gugliucci A
Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
[TBL] [Abstract][Full Text] [Related]
14. High-density lipoprotein composition and paraoxonase activity in Type I diabetes.
Valabhji J; McColl AJ; Schachter M; Dhanjil S; Richmond W; Elkeles RS
Clin Sci (Lond); 2001 Dec; 101(6):659-70. PubMed ID: 11724654
[TBL] [Abstract][Full Text] [Related]
15. Arylesterase and paraoxonase activity of paraoxonase (PON1) affected by ischemia in the plasma of patients with arterial occlusion of the lower limbs.
Kasprzak M; Iskra M; Majewski W; Wielkoszyński T
Clin Biochem; 2009 Jan; 42(1-2):50-6. PubMed ID: 18976644
[TBL] [Abstract][Full Text] [Related]
16. Paraoxonase and coronary heart disease.
Mackness MI; Mackness B; Durrington PN
Atheroscler Suppl; 2002 Dec; 3(4):49-55. PubMed ID: 12573363
[TBL] [Abstract][Full Text] [Related]
17. The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention.
Mackness MI; Durrington PN; Mackness B
Am J Cardiovasc Drugs; 2004; 4(4):211-7. PubMed ID: 15285696
[TBL] [Abstract][Full Text] [Related]
18. Unexpectedly higher diazoxon hydrolysis by serum paraoxonase-1 in coronary heart disease.
Mackness B; Mackness M
Clin Biochem; 2019 Mar; 65():21-23. PubMed ID: 30659791
[TBL] [Abstract][Full Text] [Related]
19. Paraoxonase 1 and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis.
Kotani K; Watanabe J; Miura K; Gugliucci A
Molecules; 2021 Apr; 26(8):. PubMed ID: 33923656
[TBL] [Abstract][Full Text] [Related]
20. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]